Performance analysis of Arcturus Therapeutics (ARCT)
Annual Return
Over the past 3 years, ARCT has had an average annual return of -44.00%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, ARCT has had an average annual return of -28.31%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, ARCT has had an average annual return of -14.73%, underperforming the benchmark SPY, which returned +14.95% annual.
Since May 22, 2013, ARCT has had an average annual return of -15.26%, underperforming the benchmark SPY, which returned +13.99% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.59% | -63.87% | -46.18% | +85.91% | -54.18% | -14.68% | +299.03% | +140.02% | -43.02% | -45.92% | -66.57% | +68.38% |
| 2014 | 2013 | ||||||||||
| -79.28% | +138.41% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +21.81% | +10.19% | -6.17% | +11.64% | -8.09% | -15.14% | -11.16% | -2.59% | |||||
| 2025 | +0% | -1.06% | -36.92% | +20.96% | -2.19% | +3.84% | -6.17% | +39.35% | +8.33% | -45.91% | -31.87% | -9.73% | -63.87% |
| 2024 | +4.56% | +17.57% | -12.87% | -24.29% | +51.78% | -37.26% | -3.65% | -10.07% | +10.02% | -23.61% | +3.43% | -7.46% | -46.18% |
| 2023 | +24.59% | -23.09% | +47.48% | +11.07% | +2.70% | +4.91% | +21.89% | -13.18% | -15.83% | -25.24% | +25.35% | +31.70% | +85.91% |
| 2022 | -29.40% | -8.27% | +12.48% | -28.11% | +2.59% | -20.84% | +11.52% | -19.99% | +5.53% | +19.44% | +4.18% | -8.03% | -54.18% |
| 2021 | +67.04% | -27.31% | -21.58% | -11.23% | -20.30% | +15.81% | -7.48% | +75.07% | -12.82% | -5.93% | -11.57% | -6.89% | -14.68% |
| 2020 | -5.25% | +34.48% | -1.91% | +153.91% | +12.87% | +20.03% | +11.75% | -7.64% | -11.08% | +26.07% | +69.67% | -52.72% | +299.03% |
| 2019 | +10.39% | +0.85% | +35.43% | +11.15% | -8.01% | +35.20% | +44.18% | -17.48% | -8.56% | +7.72% | +1% | -2.70% | +140.02% |
| 2018 | -2.39% | -27.79% | -1.79% | -6.72% | +15.35% | +43.30% | -5.92% | +1.52% | +9.13% | -38.79% | +15.53% | -27.56% | -43.02% |
| 2017 | -49.98% | +24.73% | -12.97% | +0.86% | -3.48% | +0.88% | -0.88% | -7.21% | -1.91% | +55.38% | -19.72% | -9.89% | -45.92% |
Drawdown analysis of Arcturus Therapeutics (ARCT)
The maximum drawdown for the ARCT was -97.70%, occurring on Dec 28, 2018. This drawdown has not yet recovered.
The current ARCT drawdown is -96.66%.
Since May 22, 2013 ARCT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.70% | Oct 7, 2013 | 1316 | Dec 28, 2018 | Ongoing | Ongoing | Ongoing |
| -14.65% | Aug 5, 2013 | 21 | Sep 4, 2013 | 4 | Sep 10, 2013 | 25 |
| -12.05% | May 22, 2013 | 22 | Jun 24, 2013 | 9 | Jul 8, 2013 | 31 |
| -7.49% | Jul 12, 2013 | 4 | Jul 18, 2013 | 10 | Aug 1, 2013 | 14 |
| -7.20% | Sep 13, 2013 | 7 | Sep 24, 2013 | 2 | Sep 26, 2013 | 9 |
| -3.58% | Sep 27, 2013 | 1 | Sep 30, 2013 | 2 | Oct 2, 2013 | 3 |